Fulcrum Therapeutics, Inc. Liquidation Value

FULC Other

Cash & Equivalents

$197.53M
As of 2025-12-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $197.53M
Total Obligations: -$19.49M
$178.04M
Per share: $2.67
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $197.53M
AR: $0
Total Obligations: -$19.49M
$178.04M
Per share: $2.67
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $197.53M
AR: $0
Inventory: $0
Total Obligations: -$19.49M
$178.04M
Per share: $2.67
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$178.04M$2.67
Liquid Liquidation Value$178.04M$2.67
Operating Liquidation Value$178.04M$2.67

Key Components (as of 2025-12-31)

Cash & Equivalents$197.53M
Accounts ReceivableN/A
InventoryN/A
Current Liabilities$13.05M
Long-term DebtN/A
Op. Lease Liability$6.44M
Finance LeaseN/A
Shares Outstanding66.6M

Explore all 131 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31$197.53MN/AN/A$1.59M$13.05MN/A$6.44MN/A
2025-09-30$47.08MN/AN/A$2.86M$11.63MN/A$7.01MN/A
2025-06-30$42.59MN/AN/A$1.75M$8.98MN/A$7.57MN/A
2025-03-31$42.18MN/AN/A$1.51M$8.10MN/A$8.11MN/A
2024-12-31$58.21MN/AN/A$1.16M$11.04MN/A$8.63MN/A
2024-09-30$72.63MN/AN/A$4.04M$14.51MN/A$9.14MN/A
2024-06-30$86.70MN/AN/A$3.58M$12.70MN/A$9.65MN/A
2024-03-31$39.95MN/AN/A$3.86M$10.69MN/A$10.14MN/A

Comments

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-24 View
2025-09-30 10-Q 2025-10-29 View
2025-06-30 10-Q 2025-07-29 View
2025-03-31 10-Q 2025-05-01 View
2024-12-31 10-K 2025-02-25 View
2024-09-30 10-Q 2024-11-13 View
2024-06-30 10-Q 2024-07-31 View
2024-03-31 10-Q 2024-05-13 View

Community Notes

Loading notes...

Questions

Loading questions...